Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Hum Immunol. 2019 May 8;80(8):595–601. doi: 10.1016/j.humimm.2019.04.016

Figure 2.

Figure 2.

A practical approach to the treatment of primary graft dysfunction. PGD: Primary Graft Dysfunction, LRA: Lung-restricted antibodies, DAD: Diffuse alveolar damage, DSA: Donor specific antibodies, IVIG: Intravenous Immune Globulins